Lupin Limited has informed the Exchange regarding a press release dated March 25, 2026, titled "Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets".
Lupin Limited has informed the Exchange regarding a press release dated March 25, 2026, titled "Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets".